479 related articles for article (PubMed ID: 33361740)
21. Invasive pulmonary aspergillosis in critically ill patients with hematological malignancies.
Pardo E; Lemiale V; Mokart D; Stoclin A; Moreau AS; Kerhuel L; Calvet L; Valade S; De Jong A; Darmon M; Azoulay E
Intensive Care Med; 2019 Dec; 45(12):1732-1741. PubMed ID: 31599334
[TBL] [Abstract][Full Text] [Related]
22. Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience.
Russo A; Falcone M; Vena A; Venditti C; Mancini C; Morelli A; Venditti M
J Chemother; 2011 Oct; 23(5):290-4. PubMed ID: 22005062
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics, radiologic findings, risk factors and outcomes of serum galactomannan-negative invasive pulmonary aspergillosis.
Jung J; Kim MY; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
J Microbiol Immunol Infect; 2018 Dec; 51(6):802-809. PubMed ID: 28712819
[TBL] [Abstract][Full Text] [Related]
24. Invasive pulmonary aspergillosis associated with COVID-19 in a kidney transplant recipient.
Trujillo H; Fernández-Ruiz M; Gutiérrez E; Sevillano Á; Caravaca-Fontán F; Morales E; López-Medrano F; Aguado JM; Praga M; Andrés A
Transpl Infect Dis; 2021 Apr; 23(2):e13501. PubMed ID: 33185971
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary Aspergillus Overlap Syndromes.
Li L; Jiang Z; Shao C
Mycopathologia; 2018 Apr; 183(2):431-438. PubMed ID: 29067630
[TBL] [Abstract][Full Text] [Related]
26. Atypical presentation of invasive pulmonary aspergillosis in a liver transplant recipient.
Mucha K; Foroncewicz B; Orłowski T; Religioni J; Bobek-Billewicz B; Jarząb B; Raczyńska J; Krawczyk M; Pączek L
Ann Transplant; 2013 May; 18():238-42. PubMed ID: 23792526
[TBL] [Abstract][Full Text] [Related]
27. Invasive Pulmonary Aspergillosis with Disseminated Infection in Immunocompetent Patient.
Moreno-González G; Ricart de Mesones A; Tazi-Mezalek R; Marron-Moya MT; Rosell A; Mañez R
Can Respir J; 2016; 2016():7984032. PubMed ID: 27445566
[TBL] [Abstract][Full Text] [Related]
28. Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract cultures.
Paiva JA; Mergulhão P; Gomes A; Taccone FS; Van den Abeele AM; Bulpa P; Misset B; Meersseman W; Dimopoulos G; Rello J; Vogelaers D; Blot S
Int J Antimicrob Agents; 2017 Oct; 50(4):529-535. PubMed ID: 28669830
[TBL] [Abstract][Full Text] [Related]
29. Invasive pulmonary aspergillosis in patients with acute-on-chronic liver failure.
Wu Z; Ling Z; Shao F; Sheng J; Li L
J Int Med Res; 2012; 40(5):1958-65. PubMed ID: 23206479
[TBL] [Abstract][Full Text] [Related]
30. [Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease].
Barberán J; Mensa J
Rev Iberoam Micol; 2014; 31(4):237-41. PubMed ID: 25481431
[TBL] [Abstract][Full Text] [Related]
31. COVID-19 Infection and Late Manifestation of Pulmonary Aspergillosis.
Bhopalwala H; Mishra V; Do TV; Gudipati M; Ganti SS
J Investig Med High Impact Case Rep; 2022; 10():23247096211063332. PubMed ID: 34984948
[TBL] [Abstract][Full Text] [Related]
32. [Invasive pulmonary aspergillosis in children with hepatic transplant: a survivor].
Botero V; García VH; Delgado A; Aristizabal AM; Gómez C; Caicedo LA; Echeverri GJ
Rev Chil Pediatr; 2018 Apr; 89(2):241-245. PubMed ID: 29799893
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for invasive pulmonary aspergillosis and hospital mortality in acute-on-chronic liver failure patients: a retrospective-cohort study.
Chen J; Yang Q; Huang J; Li L
Int J Med Sci; 2013; 10(12):1625-31. PubMed ID: 24151434
[TBL] [Abstract][Full Text] [Related]
34. Our 2015 approach to invasive pulmonary aspergillosis.
Liss B; Vehreschild JJ; Bangard C; Maintz D; Frank K; Grönke S; Michels G; Hamprecht A; Wisplinghoff H; Markiefka B; Hekmat K; Vehreschild MJ; Cornely OA
Mycoses; 2015 Jun; 58(6):375-82. PubMed ID: 25808916
[TBL] [Abstract][Full Text] [Related]
35. Invasive Pulmonary Aspergillosis.
Ledoux MP; Guffroy B; Nivoix Y; Simand C; Herbrecht R
Semin Respir Crit Care Med; 2020 Feb; 41(1):80-98. PubMed ID: 32000286
[TBL] [Abstract][Full Text] [Related]
36. Cerebral and pulmonary aspergillosis, treatment and diagnostic challenges of mixed breakthrough invasive fungal infections: case report study.
Amanati A; Lotfi M; Masoudi MS; Jafarian H; Ghasemi F; Bozorgi H; Badiee P
BMC Infect Dis; 2020 Jul; 20(1):535. PubMed ID: 32703183
[TBL] [Abstract][Full Text] [Related]
37. Uptake and efflux kinetics, and intracellular activity of voriconazole against Aspergillus fumigatus in human pulmonary epithelial cells: a new application for the prophylaxis and early treatment of invasive pulmonary aspergillosis.
Wang T; Yang Q; Chen L; Li Y; Meng T; Wang Y; Zhang T; Lei J; Xing J; Dong Y
Fundam Clin Pharmacol; 2017 Jun; 31(3):311-318. PubMed ID: 28012206
[TBL] [Abstract][Full Text] [Related]
38. [The clinical characteristics of severe influenza virus pneumonia complicated with invasive pulmonary aspergillosis: a retrospective study of 15 cases].
Huang LN; Xiong SY; Huang X; Zhan QY
Zhonghua Jie He He Hu Xi Za Zhi; 2020 May; 43(5):437-443. PubMed ID: 32450632
[No Abstract] [Full Text] [Related]
39. Role of COPD in a case of fatal
Ashby T; Green K; Burcher KM; Louis M
BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36948520
[TBL] [Abstract][Full Text] [Related]
40. A strategy for designing voriconazole dosage regimens to prevent invasive pulmonary aspergillosis based on a cellular pharmacokinetics/pharmacodynamics model.
Wang T; Zhang T; Meng T; Li Y; Chen L; Yang Q; Dong H; Lei J; Chen L; Dong Y
J Transl Med; 2018 Jun; 16(1):157. PubMed ID: 29880050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
